Pharmabiz

TN IPGA urges IPC 2026 to push for clinical pharmacist posts in 100-bed government hospitals

TN IPGA urges IPC 2026 to push for clinical pharmacist posts in 100-bed government hospitals: Peethaambaran Kunnathoor, ...
Pharmabiz

Only 2% students report seek support from therapists as overall wellbeing falls from 62% in Grade 8 to 43% in Grade 12: IC3 Institute's Student Well-being Pulse Report …

Only 2% students report seek support from therapists as overall wellbeing falls from 62% in Grade 8 to 43% in Grade 12: IC3 ...
Pharmabiz

BITS Pilani develop pharma polymer-based bioink for 3D-printed skin scaffolds and customized drug delivery

BITS Pilani develop pharma polymer-based bioink for 3D-printed skin scaffolds and customized drug delivery: Our Bureau, Mumbai Tuesday, August 25, 2026, 17:45 Hrs [IST] Researcher ...
Pharmabiz

Tulu Health expands its US presence with Longevity OS, AI-native operating system for the longevity economy

Tulu Health expands its US presence with Longevity OS, AI-native operating system for the longevity economy: Our Bureau, Bengaluru Tuesday, August 25, 2026, 15:15 Hrs [IST] Tulu H ...
Pharmabiz

Rays of Belief, operating under the brand Mom’s Belief to open IPO on September 1, 2026

Rays of Belief, operating under the brand Mom’s Belief to open IPO on September 1, 2026: Our Bureau, Bengaluru Tuesday, August 25, 2026, 17:20 Hrs [IST] Rays of Belief, which op ...
Pharmabiz

Pulnovo Medical enrols first two US patients in PULSE-LHD IDE trial of pulmonary artery denervation to treat PH associated with left heart disease

Pulnovo Medical enrols first two US patients in PULSE-LHD IDE trial of pulmonary artery denervation to treat PH associated with left heart disease: New York Tuesday, August 25, 20 ...
Pharmabiz

European Commission grants orphan designation for Lundbeck’s investigational anti-ACTH monoclonal antibody asedebart for Cushing's syndrome of endogenous origin

European Commission grants orphan designation for Lundbeck’s investigational anti-ACTH monoclonal antibody asedebart for Cushing's syndrome of endogenous origin: Valby, Denmark ...
Pharmabiz

Daiichi Sankyo appoints Ken Keller as chief commercialization officer to lead new commercialization unit to accelerate growth of innovative Portfolio

China business: Yuichi Yomasu, who currently is a corporate officer and the head of the ASCA (Asia, South and Central America) Business Unit, will lead commercialization efforts in China. A 32-year ...
Pharmabiz

Aurigene inks long-term manufacturing and supply pact with a leading global pharma company

Aurigene inks long-term manufacturing and supply pact with a leading global pharma company: Our Bureau, Bengaluru Tuesday, August 25, 2026, 17:30 Hrs [IST] Aurigene Pharmaceutical ...
Pharmabiz

Roche receives US FDA clearance for Elecsys pTau217, advancing Alzheimer’s disease assessment across primary and specialty care

Roche receives US FDA clearance for Elecsys pTau217, advancing Alzheimer’s disease assessment across primary and specialty care: Basel Tuesday, August 25, 2026, 14:00 Hrs [IST] ...
Pharmabiz

Time Medical Philippines wins digital healthcare project in Catanduanes

Time Medical International Ventures Philippines (TMIV-P), a subsidiary of Fischer Medical Ventures Limited (FMV), has been awarded a province-wide digital healthcare project for rollout across ...
Pharmabiz

US FDA accepts for priority review GSK’s sBLA for Jemperli for dMMR/MSI-H locally advanced rectal cancer

US FDA accepts for priority review GSK’s sBLA for Jemperli for dMMR/MSI-H locally advanced rectal cancer: London, UK Tuesday, August 25, 2026, 13:00 Hrs [IST] GSK plc announced ...